{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,5]],"date-time":"2026-05-05T07:23:42Z","timestamp":1777965822591,"version":"3.51.4"},"reference-count":39,"publisher":"Springer Science and Business Media LLC","issue":"5","license":[{"start":{"date-parts":[[2024,1,16]],"date-time":"2024-01-16T00:00:00Z","timestamp":1705363200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2024,1,16]],"date-time":"2024-01-16T00:00:00Z","timestamp":1705363200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"name":"Nature Science Foundation for Youth of Jiangsu Province","award":["BK20220719"],"award-info":[{"award-number":["BK20220719"]}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82370194"],"award-info":[{"award-number":["82370194"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Jiangsu Provincial Special Program of Medical Science","award":["BE2023780"],"award-info":[{"award-number":["BE2023780"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Ann Hematol"],"published-print":{"date-parts":[[2024,5]]},"DOI":"10.1007\/s00277-024-05619-w","type":"journal-article","created":{"date-parts":[[2024,1,16]],"date-time":"2024-01-16T17:02:07Z","timestamp":1705424527000},"page":"1675-1685","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":4,"title":["Cause-specific mortality in a population-level cohort of diffuse large B-cell lymphoma following chemotherapy in the early 21st century"],"prefix":"10.1007","volume":"103","author":[{"given":"Li-Ye","family":"Bei","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chun-Yu","family":"Shang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jia-Zhu","family":"Wu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hao-Rui","family":"Shen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hua","family":"Yin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jin-Hua","family":"Liang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xin-Yu","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Li","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jian-Yong","family":"Li","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yue","family":"Li","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4208-7477","authenticated-orcid":false,"given":"Wei","family":"Xu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2024,1,16]]},"reference":[{"issue":"9","key":"5619_CR1","doi-asserted-by":"publisher","first-page":"842","DOI":"10.1056\/NEJMra2027612","volume":"384","author":"LH Sehn","year":"2021","unstructured":"Sehn LH, Salles G (2021) Diffuse large B-cell lymphoma. N Engl J Med 384(9):842\u2013858. https:\/\/doi.org\/10.1056\/NEJMra2027612","journal-title":"N Engl J Med"},{"issue":"11","key":"5619_CR2","doi-asserted-by":"publisher","first-page":"e838","DOI":"10.1016\/S2352-3026(20)30222-2","volume":"7","author":"JK Lue","year":"2020","unstructured":"Lue JK, O'Connor OA (2020) A perspective on improving the R-CHOP regimen: from Mega-CHOP to robust R-CHOP, the PHOENIX is yet to rise. Lancet Haematol 7(11):e838\u2013e850. https:\/\/doi.org\/10.1016\/S2352-3026(20)30222-2","journal-title":"Lancet Haematol"},{"issue":"1","key":"5619_CR3","doi-asserted-by":"publisher","first-page":"175","DOI":"10.1186\/s13045-020-01011-z","volume":"13","author":"L Wang","year":"2020","unstructured":"Wang L, Li LR, Young KH (2020) New agents and regimens for diffuse large b cell lymphoma. J Hematol Oncol 13(1):175. https:\/\/doi.org\/10.1186\/s13045-020-01011-z","journal-title":"J Hematol Oncol"},{"issue":"5","key":"5619_CR4","doi-asserted-by":"publisher","first-page":"617","DOI":"10.1002\/ajh.26151","volume":"96","author":"S Susanibar-Adaniya","year":"2021","unstructured":"Susanibar-Adaniya S, Barta SK (2021) 2021 update on diffuse large b cell lymphoma: a review of current data and potential applications on risk stratification and management. Am J Hematol 96(5):617\u2013629. https:\/\/doi.org\/10.1002\/ajh.26151","journal-title":"Am J Hematol"},{"key":"5619_CR5","doi-asserted-by":"publisher","first-page":"107924","DOI":"10.1016\/j.pharmthera.2021.107924","volume":"229","author":"D Lavacchi","year":"2022","unstructured":"Lavacchi D, Landini I, Perrone G, Roviello G, Mini E, Nobili S (2022) Pharmacogenetics in diffuse large B-cell lymphoma treated with R-CHOP: still an unmet challenge. Pharmacol Ther 229:107924. https:\/\/doi.org\/10.1016\/j.pharmthera.2021.107924","journal-title":"Pharmacol Ther"},{"key":"5619_CR6","doi-asserted-by":"publisher","first-page":"102443","DOI":"10.1016\/j.ctrv.2022.102443","volume":"110","author":"S Poletto","year":"2022","unstructured":"Poletto S, Novo M, Paruzzo L, Frascione P, Vitolo U (2022) Treatment strategies for patients with diffuse large B-cell lymphoma. Cancer Treat Rev 110:102443. https:\/\/doi.org\/10.1016\/j.ctrv.2022.102443","journal-title":"Cancer Treat Rev"},{"issue":"11","key":"5619_CR7","doi-asserted-by":"publisher","first-page":"e781","DOI":"10.1016\/S2352-3026(21)00282-9","volume":"8","author":"M Chamuleau","year":"2021","unstructured":"Chamuleau M (2021) Dose-adjusted epoch-r plus venetoclax: a toxic bend in the road to improving R-CHOP? Lancet Haematol 8(11):e781\u2013e783. https:\/\/doi.org\/10.1016\/S2352-3026(21)00282-9","journal-title":"Lancet Haematol"},{"issue":"11","key":"5619_CR8","doi-asserted-by":"publisher","first-page":"1203","DOI":"10.1200\/JCO.20.02666","volume":"39","author":"L Oberic","year":"2021","unstructured":"Oberic L, Peyrade F, Puyade M, Bonnet C, Dartigues-Cuilleres P, Fabiani B et al (2021) Subcutaneous rituximab-minichop compared with subcutaneous rituximab-minichop plus lenalidomide in diffuse large B-cell lymphoma for patients age 80 years or older. J Clin Oncol 39(11):1203\u20131213. https:\/\/doi.org\/10.1200\/JCO.20.02666","journal-title":"J Clin Oncol"},{"issue":"4","key":"5619_CR9","doi-asserted-by":"publisher","first-page":"903","DOI":"10.1200\/JCO.22.01848","volume":"41","author":"LJ Nastoupil","year":"2023","unstructured":"Nastoupil LJ, Bartlett NL (2023) Navigating the evolving treatment landscape of diffuse large B-cell lymphoma. J Clin Oncol 41(4):903\u2013913. https:\/\/doi.org\/10.1200\/JCO.22.01848","journal-title":"J Clin Oncol"},{"issue":"3","key":"5619_CR10","doi-asserted-by":"publisher","first-page":"281","DOI":"10.1016\/j.jaccao.2023.05.001","volume":"5","author":"S Kambhampati","year":"2023","unstructured":"Kambhampati S, Herrera AF, Rhee JW (2023) How to treat diffuse large B-cell lymphoma: oncologic and cardiovascular considerations. Jacc Cardiooncol 5(3):281\u2013291. https:\/\/doi.org\/10.1016\/j.jaccao.2023.05.001","journal-title":"Jacc Cardiooncol"},{"issue":"10","key":"5619_CR11","doi-asserted-by":"publisher","first-page":"631","DOI":"10.1038\/s41571-020-0378-y","volume":"17","author":"F Islami","year":"2020","unstructured":"Islami F, Siegel RL, Jemal A (2020) The changing landscape of cancer in the USA - opportunities for advancing prevention and treatment. Nat Rev Clin Oncol 17(10):631\u2013649. https:\/\/doi.org\/10.1038\/s41571-020-0378-y","journal-title":"Nat Rev Clin Oncol"},{"issue":"4","key":"5619_CR12","doi-asserted-by":"publisher","first-page":"252","DOI":"10.3322\/caac.21235","volume":"64","author":"CE Desantis","year":"2014","unstructured":"Desantis CE, Lin CC, Mariotto AB, Siegel RL, Stein KD, Kramer JL et al (2014) (2014) Cancer treatment and survivorship statistics. Ca Cancer J Clin 64(4):252\u2013271. https:\/\/doi.org\/10.3322\/caac.21235","journal-title":"Ca Cancer J Clin"},{"issue":"1","key":"5619_CR13","doi-asserted-by":"publisher","first-page":"238","DOI":"10.1038\/leu.2015.120","volume":"30","author":"TP Vassilakopoulos","year":"2016","unstructured":"Vassilakopoulos TP, Pangalis GA, Chatziioannou S et al (2016) PET\/CT in primary mediastinal large B-cell lymphoma responding to rituximab-CHOP: an analysis of 106 patients regarding prognostic significance and implications for subsequent radiotherapy. Leukemia 30(1):238\u2013242. https:\/\/doi.org\/10.1038\/leu.2015.120","journal-title":"Leukemia"},{"issue":"9","key":"5619_CR14","doi-asserted-by":"publisher","first-page":"971","DOI":"10.1182\/blood.2020008377","volume":"140","author":"RS Lauren","year":"2022","unstructured":"Lauren RS, Christian G (2022) Primary central nervous system lymphoma. Blood 140(9):971\u2013979. https:\/\/doi.org\/10.1182\/blood.2020008377","journal-title":"Blood"},{"issue":"1","key":"5619_CR15","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1038\/s41572-019-0060-9","volume":"5","author":"E Cesarman","year":"2019","unstructured":"Cesarman E, Damania B, Krown SE, Martin J, Bower M, Whitby D (2019) Kaposi sarcoma. Nat Rev Dis Primers 5(1):9. https:\/\/doi.org\/10.1038\/s41572-019-0060-9","journal-title":"Nat Rev Dis Primers"},{"key":"5619_CR16","doi-asserted-by":"publisher","unstructured":"Martin DB, Silas S, Covner A, Hendrie PC, Stewart FM (2015) Development of a hematology\/oncology ICD-10 documentation job aid. J Natl Compr Canc Netw 13(4):435-40. https:\/\/doi.org\/10.6004\/jnccn.2015.0059","DOI":"10.6004\/jnccn.2015.0059"},{"issue":"2","key":"5619_CR17","doi-asserted-by":"publisher","first-page":"400","DOI":"10.1093\/annonc\/mdw604","volume":"28","author":"NG Zaorsky","year":"2017","unstructured":"Zaorsky NG, Churilla TM, Egleston BL, Fisher SG, Ridge JA, Horwitz EM et al (2017) Causes of death among cancer patients. Ann Oncol 28(2):400\u2013407. https:\/\/doi.org\/10.1093\/annonc\/mdw604","journal-title":"Ann Oncol"},{"issue":"17","key":"5619_CR18","doi-asserted-by":"publisher","first-page":"3326","DOI":"10.1002\/cncr.30739","volume":"123","author":"N Howlader","year":"2017","unstructured":"Howlader N, Mariotto AB, Besson C et al (2017) Cancer-specific mortality, cure fraction, and noncancer causes of death among diffuse large B-cell lymphoma patients in the immunochemotherapy era. Cancer 123(17):3326\u20133334. https:\/\/doi.org\/10.1002\/cncr.30739","journal-title":"Cancer"},{"issue":"20","key":"5619_CR19","doi-asserted-by":"publisher","first-page":"1584","DOI":"10.1093\/jnci\/djq366","volume":"102","author":"N Howlader","year":"2010","unstructured":"Howlader N, Ries LA, Mariotto AB et al (2010) Improved estimates of cancer-specific survival rates from population-based data. J Natl Cancer Inst 102(20):1584\u20131598. https:\/\/doi.org\/10.1093\/jnci\/djq366","journal-title":"J Natl Cancer Inst"},{"issue":"1","key":"5619_CR20","doi-asserted-by":"publisher","first-page":"117","DOI":"10.1016\/j.eururo.2022.11.023","volume":"84","author":"EJ Schafer","year":"2023","unstructured":"Schafer EJ, Jemal A, Wiese D, Sung H, Kratzer TB, Islami F et al (2023) Disparities and trends in genitourinary cancer incidence and mortality in the USA. Eur Urol 84(1):117\u2013126. https:\/\/doi.org\/10.1016\/j.eururo.2022.11.023","journal-title":"Eur Urol"},{"issue":"1","key":"5619_CR21","doi-asserted-by":"publisher","first-page":"22","DOI":"10.1186\/s13045-019-0706-9","volume":"12","author":"W Liu","year":"2019","unstructured":"Liu W, Liu J, Song Y, Wang X, Zhou M, Wang L et al (2019) Mortality of lymphoma and myeloma in China, 2004-2017: an observational study. J Hematol Oncol 12(1):22. https:\/\/doi.org\/10.1186\/s13045-019-0706-9","journal-title":"J Hematol Oncol"},{"issue":"21","key":"5619_CR22","doi-asserted-by":"publisher","first-page":"2113","DOI":"10.1001\/jama.2019.6560","volume":"321","author":"MS Ekker","year":"2019","unstructured":"Ekker MS, Verhoeven JI, Vaartjes I, Jolink W, Klijn C, de Leeuw FE (2019) Association of stroke among adults aged 18 to 49 years with long-term mortality. Jama 321(21):2113\u20132123. https:\/\/doi.org\/10.1001\/jama.2019.6560","journal-title":"Jama"},{"issue":"4","key":"5619_CR23","doi-asserted-by":"publisher","first-page":"309","DOI":"10.3322\/caac.21341","volume":"66","author":"G Curigliano","year":"2016","unstructured":"Curigliano G, Cardinale D, Dent S, Criscitiello C, Aseyev O, Lenihan D et al (2016) Cardiotoxicity of anticancer treatments: epidemiology, detection, and management. Ca Cancer J Clin 66(4):309\u2013325. https:\/\/doi.org\/10.3322\/caac.21341","journal-title":"Ca Cancer J Clin"},{"issue":"8","key":"5619_CR24","doi-asserted-by":"publisher","first-page":"e445","DOI":"10.1016\/S1470-2045(17)30535-1","volume":"18","author":"BE Levis","year":"2017","unstructured":"Levis BE, Binkley PF, Shapiro CL (2017) Cardiotoxic effects of anthracycline-based therapy: what is the evidence and what are the potential harms? Lancet Oncol 18(8):e445\u2013e456. https:\/\/doi.org\/10.1016\/S1470-2045(17)30535-1","journal-title":"Lancet Oncol"},{"issue":"9","key":"5619_CR25","doi-asserted-by":"publisher","first-page":"938","DOI":"10.1016\/j.jacc.2014.06.1167","volume":"64","author":"P Vejpongsa","year":"2014","unstructured":"Vejpongsa P, Yeh ET (2014) Prevention of anthracycline-induced cardiotoxicity: challenges and opportunities. J Am Coll Cardiol 64(9):938\u2013945. https:\/\/doi.org\/10.1016\/j.jacc.2014.06.1167","journal-title":"J Am Coll Cardiol"},{"issue":"3","key":"5619_CR26","doi-asserted-by":"publisher","first-page":"292","DOI":"10.1016\/j.jaccao.2023.05.004","volume":"5","author":"PA Henriksen","year":"2023","unstructured":"Henriksen PA, Rankin S, Lang NN (2023) Cardioprotection in patients at high risk of anthracycline-induced cardiotoxicity: jacc: cardiooncology primer. Jacc Cardiooncol 5(3):292\u2013297. https:\/\/doi.org\/10.1016\/j.jaccao.2023.05.004","journal-title":"Jacc Cardiooncol"},{"issue":"6","key":"5619_CR27","doi-asserted-by":"publisher","first-page":"681","DOI":"10.1111\/joim.12889","volume":"285","author":"TA Eyre","year":"2019","unstructured":"Eyre TA, Martinez-Calle N, Hildyard C, Eyre DW, Plaschkes H, Griffith J et al (2019) Impact of intended and relative dose intensity of R-CHOP in a large, consecutive cohort of elderly diffuse large B-cell lymphoma patients treated with curative intent: no difference in cumulative incidence of relapse comparing patients by age. J Intern Med 285(6):681\u2013692. https:\/\/doi.org\/10.1111\/joim.12889","journal-title":"J Intern Med"},{"issue":"4","key":"5619_CR28","doi-asserted-by":"publisher","first-page":"924","DOI":"10.1016\/j.immuni.2019.03.024","volume":"50","author":"E Batlle","year":"2019","unstructured":"Batlle E, Massague J (2019) Transforming growth factor-beta signaling in immunity and cancer. Immunity 50(4):924\u2013940. https:\/\/doi.org\/10.1016\/j.immuni.2019.03.024","journal-title":"Immunity"},{"issue":"3","key":"5619_CR29","doi-asserted-by":"publisher","first-page":"421","DOI":"10.1016\/j.ccell.2023.01.009","volume":"41","author":"EN Arner","year":"2023","unstructured":"Arner EN, Rathmell JC (2023) Metabolic programming and immune suppression in the tumor microenvironment. Cancer Cell 41(3):421\u2013433. https:\/\/doi.org\/10.1016\/j.ccell.2023.01.009","journal-title":"Cancer Cell"},{"key":"5619_CR30","doi-asserted-by":"publisher","unstructured":"Skurlova M, Holubova K, Kleteckova L, Kozak T, Kubova H, Horacek J et al (2023) Chemobrain in blood cancers: how chemotherapeutics interfere with the brain\u2019s structure and functionality, immune system, and metabolic functions. Med Res Rev. https:\/\/doi.org\/10.1002\/med.21977","DOI":"10.1002\/med.21977"},{"issue":"8","key":"5619_CR31","doi-asserted-by":"publisher","first-page":"79","DOI":"10.1038\/s41408-020-00346-7","volume":"10","author":"K Wudhikarn","year":"2020","unstructured":"Wudhikarn K, Palomba ML, Pennisi M, Garcia-Recio M, Flynn JR, Devlin SM et al (2020) Infection during the first year in patients treated with CD19 CAR T cells for diffuse large B cell lymphoma. Blood Cancer J 10(8):79. https:\/\/doi.org\/10.1038\/s41408-020-00346-7","journal-title":"Blood Cancer J"},{"issue":"8","key":"5619_CR32","doi-asserted-by":"publisher","first-page":"2229","DOI":"10.1182\/bloodadvances.2021004286","volume":"5","author":"TA Eyre","year":"2021","unstructured":"Eyre TA, Wilson W, Kirkwood AA, Wolf J, Hildyard C, Plaschkes H et al (2021) Infection-related morbidity and mortality among older patients with DLBCL treated with full- or attenuated-dose R-CHOP. Blood Adv 5(8):2229\u20132236. https:\/\/doi.org\/10.1182\/bloodadvances.2021004286","journal-title":"Blood Adv"},{"issue":"10308","key":"5619_CR33","doi-asserted-by":"publisher","first-page":"1359","DOI":"10.1016\/S0140-6736(21)01374-X","volume":"398","author":"P Gines","year":"2021","unstructured":"Gines P, Krag A, Abraldes JG, Sola E, Fabrellas N, Kamath PS (2021) Liver cirrhosis. Lancet 398(10308):1359\u20131376. https:\/\/doi.org\/10.1016\/S0140-6736(21)01374-X","journal-title":"Lancet"},{"issue":"6","key":"5619_CR34","doi-asserted-by":"publisher","first-page":"1209","DOI":"10.1016\/j.cgh.2021.03.005","volume":"20","author":"IA Rowe","year":"2022","unstructured":"Rowe IA, Wong VW, Loomba R (2022) Treatment candidacy for pharmacologic therapies for NASH. Clin Gastroenterol Hepatol 20(6):1209\u20131217. https:\/\/doi.org\/10.1016\/j.cgh.2021.03.005","journal-title":"Clin Gastroenterol Hepatol"},{"issue":"3","key":"5619_CR35","doi-asserted-by":"publisher","first-page":"e129","DOI":"10.1016\/S1470-2045(21)00639-2","volume":"23","author":"MI Printezi","year":"2022","unstructured":"Printezi MI, Kilgallen AB, Bond M, Stibler U, Putker M, Teske AJ et al (2022) Toxicity and efficacy of chronomodulated chemotherapy: a systematic review. Lancet Oncol 23(3):e129\u2013e143. https:\/\/doi.org\/10.1016\/S1470-2045(21)00639-2","journal-title":"Lancet Oncol"},{"issue":"5","key":"5619_CR36","doi-asserted-by":"publisher","first-page":"289","DOI":"10.1038\/nrclinonc.2013.41","volume":"10","author":"LB Travis","year":"2013","unstructured":"Travis LB, Demark WW, Allan JM, Wood ME, Ng AK (2013) Aetiology, genetics and prevention of secondary neoplasms in adult cancer survivors. Nat Rev Clin Oncol 10(5):289\u2013301. https:\/\/doi.org\/10.1038\/nrclinonc.2013.41","journal-title":"Nat Rev Clin Oncol"},{"issue":"6","key":"5619_CR37","doi-asserted-by":"publisher","first-page":"832","DOI":"10.1001\/jamaoncol.2017.3605","volume":"4","author":"CC Murphy","year":"2018","unstructured":"Murphy CC, Gerber DE, Pruitt SL (2018) Prevalence of prior cancer among persons newly diagnosed with cancer: an initial report from the surveillance, epidemiology, and end results program. Jama Oncol 4(6):832\u2013836. https:\/\/doi.org\/10.1001\/jamaoncol.2017.3605","journal-title":"Jama Oncol"},{"key":"5619_CR38","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1097\/01.MLR.0000020942.47004.03","volume":"40","author":"JL Warren","year":"2002","unstructured":"Warren JL, Klabunde CN, Schrag D et al (2002) Overview of the SEER-Medicare data: content, research applications, and generalizability to the United States elderly population. Med Care 40:3\u201318. https:\/\/doi.org\/10.1097\/01.MLR.0000020942.47004.03","journal-title":"Med Care"},{"issue":"1","key":"5619_CR39","doi-asserted-by":"publisher","first-page":"7","DOI":"10.3322\/caac.21708","volume":"72","author":"RL Siegel","year":"2022","unstructured":"Siegel RL, Miller KD, Fuchs HE et al (2022) (2022) Cancer statistics. Ca Cancer J Clin 72(1):7\u201333. https:\/\/doi.org\/10.3322\/caac.21708","journal-title":"Ca Cancer J Clin"}],"container-title":["Annals of Hematology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00277-024-05619-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00277-024-05619-w\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00277-024-05619-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,4,12]],"date-time":"2024-04-12T06:03:55Z","timestamp":1712901835000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00277-024-05619-w"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,1,16]]},"references-count":39,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2024,5]]}},"alternative-id":["5619"],"URL":"https:\/\/doi.org\/10.1007\/s00277-024-05619-w","relation":{},"ISSN":["0939-5555","1432-0584"],"issn-type":[{"value":"0939-5555","type":"print"},{"value":"1432-0584","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,1,16]]},"assertion":[{"value":"4 September 2023","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"4 January 2024","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"16 January 2024","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors have no relevant financial or non-financial interests to disclose.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval"}},{"value":"Not applicable","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent to participate"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}